• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Enochian Biosciences Inc (NQ: ENOB )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 4, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Enochian Biosciences Inc

    < Previous 1 2 3 Next >
    BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Participating in Webinar Focused on Future Health Tech
    Via Investor Brand Network
    BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Releases Shareholder Letter Regarding Agreement to Combine with Leading AI Company
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDiCube on New Joint Effort Clinical Trials
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Clear Path to IND Submission for Innovative Cancer Platform
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Discusses Substantial Scientific, Product Development Advances in Letter to Shareholders
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Presentation of ‘Impressive’ Results from Proof-of-Concept Studies
    Via Investor Brand Network
    BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Bright Future in Advancing Potentially Curative Therapies
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Committed to Rapid Advancement of Its Proprietary Oncology Platform
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Renovaro BioSciences (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting
    From Enochian BioSciences, Inc.
    Via GlobeNewswire
    Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review
    From Enochian BioSciences, Inc.
    Via GlobeNewswire
    Enochian BioSciences’ CEO Letter to Shareholders
    Turning the Page; A Promising Future 
    From Enochian BioSciences, Inc.
    Via GlobeNewswire
    Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher
    From Enochian BioSciences, Inc.
    Via GlobeNewswire
    Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements
    From Enochian BioSciences, Inc.
    Via GlobeNewswire
    Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022
    From Enochian BioSciences, Inc.
    Via GlobeNewswire
    Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022
    From Enochian BioSciences, Inc.
    Via GlobeNewswire
    NASDAQ:ENOB Long-Term Investor Notice: Investigation over Potential Wrongdoing at Enochian Biosciences, Inc.
    San Diego, CA -- (SBWIRE) -- 11/09/2022 -- Certain directors of Enochian Biosciences, Inc. are under investigation over possible breaches of fiduciary duties. 
    Via SBWire
    Enochian BioSciences Forges Ahead With Focused Approach, Promising Future
    From Enochian BioSciences, Inc.
    Via GlobeNewswire
    Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K
    From Enochian BioSciences, Inc.
    Via GlobeNewswire
    Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform
    Initial, Pre-Clinical Animal Study Results Show Potential To Effectively Treat Pancreatic Cancer 
    From Enochian BioSciences, Inc.
    Via GlobeNewswire
    ENOCHIAN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    ENOB FINAL DEADLINE MONDAY: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ENOB FINAL DEADLINE NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.